Correlation Between Spero Therapeutics and Puma Biotechnology
Can any of the company-specific risk be diversified away by investing in both Spero Therapeutics and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spero Therapeutics and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spero Therapeutics and Puma Biotechnology, you can compare the effects of market volatilities on Spero Therapeutics and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spero Therapeutics with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spero Therapeutics and Puma Biotechnology.
Diversification Opportunities for Spero Therapeutics and Puma Biotechnology
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Spero and Puma is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Spero Therapeutics and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and Spero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spero Therapeutics are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of Spero Therapeutics i.e., Spero Therapeutics and Puma Biotechnology go up and down completely randomly.
Pair Corralation between Spero Therapeutics and Puma Biotechnology
Given the investment horizon of 90 days Spero Therapeutics is expected to under-perform the Puma Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Spero Therapeutics is 1.16 times less risky than Puma Biotechnology. The stock trades about -0.02 of its potential returns per unit of risk. The Puma Biotechnology is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 279.00 in Puma Biotechnology on December 5, 2024 and sell it today you would earn a total of 60.00 from holding Puma Biotechnology or generate 21.51% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Spero Therapeutics vs. Puma Biotechnology
Performance |
Timeline |
Spero Therapeutics |
Puma Biotechnology |
Spero Therapeutics and Puma Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Spero Therapeutics and Puma Biotechnology
The main advantage of trading using opposite Spero Therapeutics and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spero Therapeutics position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.Spero Therapeutics vs. Assembly Biosciences | Spero Therapeutics vs. Achilles Therapeutics PLC | Spero Therapeutics vs. Instil Bio | Spero Therapeutics vs. CytomX Therapeutics |
Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |